Sio Gene Therapies Inc.: Nasdaq/NYSE listing notice — Sio Gene Therapies receives Nasdaq delisting notice; will not appeal due to planned dissolution

Sio Gene Therapies Inc.

Nasdaq notified Sio on March 14, 2023, that common stock will be delisted for failure to meet minimum bid price requirement.
Company will not appeal the delisting determination in light of its planned complete liquidation and dissolution.
Trading of Sio's common stock expected to be suspended at the open on March 23, 2023; Form 25-NSE to be filed.
Dissolution plan is pending stockholder approval via proxy statement filed February 21, 2023, with SEC.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Sio Gene Therapies Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5450(a)(1)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: minimum bid price
Rules: 5450(a)(1)

Exact text from the filing

March 14, 2023, the Company received written notice (the “ Delisting Notice ”) from Nasdaq notifying the Company that, as a result of its failure to regain compliance with the Minimum Bid Price Requirement, Nasdaq has determined that the Company’s common stock will be delisted from the Nasdaq Capital Market. In light of the Company’s planned Dissolution, the Company will not appeal this determination. The Company expects, based on the Delisting Notice, that trading of the Company’s common stock will be suspended at the opening of business on March 23, 2023, and a Form 25-NSE will be filed with

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001636050-23-000011

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.